Etc., the digital and startup incubation hub of BT Group, has scaled up its preventative remote care initiative in the North of England, which will see 238,000 patients benefit from efforts to prevent, detect…
Continue Reading
The monitoring of physiological parameters is a crucial topic in promoting human health and an indispensable approach for assessing physiological status and diagnosing diseases. Particularly, it holds significant value for patients who require long-term…
Continue Reading
Cleerly, a leading innovator in the field of cardiovascular disease diagnosis, today announced the launch of the TRANSFORM trial at the American Heart Association’s (AHA) 2023 Scientific Sessions. This groundbreaking trial aims to revolutionize…
Continue Reading
Boston-based medical technology company Elucid, which offers AI-enabled imaging analysis software for cardiovascular disease, announced that it has scored $80 million in Series C funding, bringing its total raise to $121 million.Elevage Medical Technologies…
Continue Reading
What You Should Know: – Elucid, a medical technology company providing AI-powered imaging analysis software to assess cardiovascular disease, has raised $80M in Series C funding led by Elevage Medical Technologies, with additional participation…
Continue Reading
By Shania Kennedy
November 06, 2023 – Artificial intelligence (AI) and deep learning tools may be capable of accurately detecting heart valve disease and predicting the risk of cardiovascular disease events, according to two preliminary research…
Continue Reading
Musculoskeletal care is a critical service line in healthcare. More than 50% of the adult population in the U.S. has some form of MSK condition, and the impact on people’s lives is significant.THE PROBLEM
Pain…
Mount Sinai has teamed up with the Chiba Institute of Technology to integrate artificial intelligence (AI) into cardiovascular research, aiming to accelerate patient care and treatment innovations. This collaboration holds global significance in addressing…
Continue Reading
The Icahn School of Medicine at Mount Sinai has signed a memorandum of understanding with the Chiba Institute of Technology to use artificial intelligence to enhance clinical trials for cardiovascular disease, advance patient care…
Continue Reading
Nano-X Imaging’s HealthCCSng AI solution, developed by Nanox.AI, revealed previously undetected cardiovascular risk in 58% of patients during a study conducted at Israel’s Beilinson Hospital. This innovative technology automatically analyzed coronary artery calcium (CAC)…
Continue Reading
